RecruitingPhase 4NCT07254715

Effect of Itopride on Semaglutide Gastroparesis

Does Itopride Improve Semaglutide Induced Gastroparesis Ultrasound Before Anesthesia? Randomized Controlled Trial


Sponsor

Ain Shams University

Enrollment

60 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Semaglutide delays gastric emptying and increases the risk of aspiration with anesthesia; So, the addition of prokinetics as Itopride, could enhance gastric emptying and hasten surgery. The investigator will evaluate the effect of Itopride on Semaglutide-induced gastroparesis and residual gastric contents after 8 hours of fasting by gastric ultrasound before anesthesia.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years

Inclusion Criteria5

  • American Society of Anesthesiologists grade I- III.
  • Age: 40-60 years.
  • BMI: 20-30 kg/m2.
  • Diabetic patients on semaglutide (0.5-1mg) SC weekly.
  • Undergoing elective hysterectomy.

Exclusion Criteria7

  • Declining to give written informed consent.
  • history of upper abdominal surgery or the presence of hiatal hernia.
  • Other medications inducing gastroparesis (opioids, proton pump inhibitors, tricyclic antidepressants, calcium channel blockers, antipsychotic medications, and lithium).
  • History of allergy to Itopride.
  • History of cardiac arrhythmia or abnormal ECG.
  • Neurologic diseases (including Parkinson's disease and multiple sclerosis)
  • Hepatic or renal failure.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGItopride HCI 50 mg

Daily oral 50mg Itopride tablet TID, 1 hour before meals for 7 days

DRUGPlacebo

Daily placebo tablet TID, 1 hour before meals for 7 days


Locations(1)

faculty of medicine, Ain Shams University

Cairo, Cairo Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07254715


Related Trials